Just three weeks after vehemently defending its proposed acquisition of Valtech Cardio Ltd. (Yehuda, Israel), Heartware International Inc. (Framingham, Mass.) nixed the stock-based deal, which was valued at $929 million and announced in September.
With nearly $20 billion of net cash, the industry can expect to see "disciplined and decisive actions" from Johnson & Johnson (J&J; New Brunswick, N.J.) regarding mergers and acquisitions this year, CEO Alex Gorsky said during the company's fourth-quarter earnings call.
Inhalers are getting smarter with the help of digital health technology from Adherium Group (Auckland, New Zealand). CEO Garth Southerland, who has had severe asthma his entire life, founded the company in 2001.
While stocks fell deep into the red across the board Wednesday, Glaukos Corp.'s (Laguana Hills, Calif.) share price (NYSE; GKOS) moved into the g reen by just a pinch after the company reported positive long-term data from an international study of its micro-bypass stent for glaucoma.
SAN FRANCISCO — Surgeons have only had one robot to play with in the general surgery space since Intutive Surgical Inc. (Sunnyvale, Calif.) introduced the da Vinci system in 1999, but that's about to change as Transenterix Inc. (Morrisville, N.C.) prepares to launch its recently-acquired Alf-x robotic system in Europe and its Surgibot system in the U.S.
SAN FRANCISCO — As Medtronic plc (Dublin) approaches the anniversary of its blockbuster Covidien deal, which closed a year ago this month, the company is making strides to prove the $42.9 billion acquisition is paying off.
